We are live on ! Find out more
HCM

Hamlin Capital Management Portfolio holdings

AUM $4.45B
1-Year Est. Return 22.95%
This Fund
S&P 500
This Quarter Est. Return
-2.34%
1 Year Est. Return
+22.95%
3 Year Est. Return
+71.55%
5 Year Est. Return
+101.48%
10 Year Est. Return
+266.63%
AUM
$2.91B
AUM Growth
-$78.1M
Cap. Flow
+$22.4M
Cap. Flow %
0.77%
Top 10 Hldgs %
47.24%
Holding
26
New
Increased
13
Reduced
13
Closed

Top Buys

Rank Stock Value
1
MS icon
Morgan Stanley
MS
+$37.3M
2
WSO icon
Watsco Inc
WSO
+$16.7M
3
UL icon
Unilever
UL
+$7.26M
4
TXN icon
Texas Instruments
TXN
+$7.24M
5
KDP icon
Keurig Dr Pepper
KDP
+$6.65M

Sector Composition

Rank Sector Weight
1 Financials 17.51%
2 Industrials 14.36%
3 Technology 13.24%
4 Consumer Staples 12.85%
5 Energy 10.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPG
26
DELISTED
Interpublic Group of Companies
IPG
$56.2M 1.93%
1,962,119
-425,221
-18% -$14.2M

Similar funds

Hamlin Capital Management's Q3 2023 Portfolio in Review

As of Q3 2023, Hamlin Capital Management held 26 positions worth $2.91B, down 2.6% from $2.98B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 0%. Hamlin Capital Management opened no new positions and made no exits, leaving the 26-position portfolio largely intact.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

  • Hamlin Capital Management added most to Morgan Stanley in Q3 2023, an estimated $37.3M increase.
  • Hamlin Capital Management's biggest Q3 2023 reduction was Interpublic Group of Companies, cutting an estimated $14.2M.
  • Hamlin Capital Management's ten largest holdings make up 47% of its $2.91B portfolio in Q3 2023.
  • Hamlin Capital Management opened 0 new positions and closed 0 in Q3 2023.
  • Hamlin Capital Management's portfolio value fell 2.6% quarter-over-quarter to $2.91B.

Based on Hamlin Capital Management's 13F filing for Q3 2023, filed 4 Oct 2023.